Category | Incidences | Odds Ratio (95% CI) | Incidences | Odds Ratio (95% CI) | ||
AspirinÒ Complex N = 375 | Placebo N = 317 | AspirinÒ Complex N = 375 | Placebo N = 317 | |||
Adverse Events | Drug-Related Adverse Events | |||||
All Adverse Events | 13.6% | 11.0% | 1.20 (0.75 - 1.92) | 5.9% | 3.8% | 1.59 (0.76 - 3.35) |
All Gastrointestinal Adverse Events | 7.5% | 4.4% | 1.76 (0.90 - 3.48) | 4.8% | 2.2% | 2.32 (0.93 - 5.82) |
Dyspepsia | 0.5% | 0.3% | 1.56 (0.12 - 20.84) | 0.3% | 0.3% | 0.83 (0.04 - 16.13) |
Nausea | 3.5% | 1.9% | 1.83 (0.69 - 4.89) | 2.4% | 0.9% | 2.70 (0.70 - 10.38) |
Minor gastrointestinal disorders* | 6.4% | 3.5% | 1.82 (0.87 - 3.83) | 4.3% | 1.9% | 2.41 (0.91 - 6.40) |
Central nervous system stimulation** | 1.9% | 0.9% | 1.67 (0.43 - 6.57) | 0.5% | 0.6% | 0.85 (0.12 - 6.05) |